Ligand Pharmaceuticals (LGND) Q1 2021 Earnings

3FebConfirmed
Q2 2020
Q3 2020
Q4 2020
Q1 2021
0.66
0.98
1.3
1.62

Details

Expected EPS
1
Actual EPS
1.62
Surprise EPS
0.62
Surprise Percent
+62%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 1.62 per share for Q1 2021.

0 Comments

Share your thoughts